Artificial Intelligence in Global Epidemics, Part 2

Although the number of confirmed COVID-19 cases is still relatively high (see Figure 1), the interest of the general public in the COVID-19 pandemic is almost coming to an end (see Figure 2). One might expect an analogous trend for the interest of researchers in the COVID-19 pandemic. However, the availability of preliminary data and previous research results as the basis of current and future research seems to encourage researchers to provide more useful data at global level. It looks quite obvious that the results of the current research in the area of COVID-19 are published in numerous scientific contributions in recent times (see Figure 3). We expect this number will continue to rise, because the year 2022 is not over yet and it takes some time until bibliographic databases add the metadata of recent publications. Furthermore, in 2020, informal publications were the dominant form of publication promising a fast publication process; this has supported timely discussions among researchers about the new COVID-19 illness for fast medical solutions. Since 2021, peer-reviewed publications like journal articles, which are known for more mature and productive research results, have dominated.


Introduction
Although the number of confirmed COVID-19 cases is still relatively high (see Figure 1), the interest of the general public in the COVID-19 pandemic is almost coming to an end (see Figure 2).One might expect an analogous trend for the interest of researchers in the COVID-19 pandemic.However, the availability of preliminary data and previous research results as the basis of current and future research seems to encourage researchers to provide more useful data at global level.It looks quite obvious that the results of the current research in the area of COVID-19 are published in numerous scientific contributions in recent times (see Figure 3).We expect this number will continue to rise, because the year 2022 is not over yet and it takes some time until bibliographic databases add the metadata of recent publications.Furthermore, in 2020, informal publications were the dominant form of publication promising a fast publication process; this has supported timely discussions among researchers about the new COVID-19 illness for fast medical solutions.Since 2021, peer-reviewed publications like journal articles, which are known for more mature and productive research results, have dominated.
Because of this large number of continuous research results, our special issue also received a high number of submissions, such that the included articles have been too This special issue solicits submissions focusing on the perspectives and surveys of existing scenarios and consisting of research results in the following, but not limited to, topics: -Effects of COVID-19 Confinements -Assessing Countries' readiness for coping with epidemics -Studies related to animal originated diseases -Challenges in battling with epidemics -AI for forecasting -AI and detection -Generating recommendations -AI in genome sequencing -AI-assisted testing -Role of AI in contact tracing -Situation awareness -Computational drug repurposing The topics of our selected papers are many fold.While many contributions focus on image processing and detection of COVID-19 [3,8,11,14], there is also a shift to multi-disease prediction [10] and predicting post-COVID-19 complications [5], which have not been addressed in research in the early days of COVID-19.
Sentiment analysis [1,13] continues to be a topic of interest as it was in the times of the COVID-19 pandemic.Not only the data from social media [13] is used, but also the data from other data sources like hospital reviews [1], which is a sign of the availability of more and more different types of data sources and hence better possibilities for research.
We hope you enjoy reading the papers and help you to understand the current status of COVID-19-related research.We also hope these papers will provide you with some directions for research in this area.We believe that COVID-19 will remain a major focus for further research and experimentation in the times to come.
Funding Open Access funding enabled and organized by Projekt DEAL.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit http:// creat iveco mmons.org/ licen ses/ by/4.0/.